Endometrial Cancer Trial, Recruiting NCT06692335 Sponsor: Chinese University of Hong Kong Condition: Endometrial Cancer
Back to Endometrial Cancer

Endometrial Cancer Trial, Recruiting

NCT06692335
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged 18 to 50 years old
  • People who are pre-menopausal or in the early stages of menopause, with a hormone level (FSH) below 25 mIU/ml
  • People with a body mass index (BMI) under 33, or where the tissue layer of the abdominal wall measures less than 5 cm
  • People whose uterus is no larger than the size typically seen at 18 weeks of pregnancy, based on a physical examination
  • People who have a fibroid (a non-cancerous growth in the uterus) that sits within the uterine wall, measures between 3 cm and 10 cm, and is the largest one present on imaging
  • People whose fibroids are causing symptoms such as heavy periods, a feeling of pressure, or pelvic pain
  • People who are willing and able to give their informed consent to participate

Who may not be able to join:

  • People who have another growth or condition in the pelvic area, such as endometriosis, an abnormal mass on the ovaries, an ovarian tumour, or pelvic inflammatory disease (either current or ongoing)
  • People with severe obesity
  • People who are unable to lie face-down for more than 2 hours
  • People who have significant scarring on the abdomen in the area where sound waves would need to pass through during treatment
  • People who are pregnant, breastfeeding, or have gone through menopause
  • People where a pre-cancerous or cancerous condition of the uterus cannot be confidently ruled out through clinical assessment and MRI
  • People whose fibroids have grown very rapidly, meaning they doubled in size within 6 months
  • People who have had, or currently have, a blood clot condition such as deep vein thrombosis, a pulmonary embolus (clot in the lungs), or a stroke
  • People who have a blood clotting disorder or who take medication that affects how their blood clots
  • People who have previously had radiation treatment to the pelvic area
  • People with a specific type of fibroid (called pedunculated) that hangs from a narrow stalk, measures 5 cm or larger, and where the stalk is less than 25% of the fibroid's width
  • People with fibroids located in or around the cervix or broad ligament area of the uterus
  • People who are unable to have an MRI scan, due to severe claustrophobia or having a metal implant in their body
  • People who also have adenomyosis (a condition where the uterine lining grows into the uterine wall)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 21 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Shing Chee Chan, Chinese University of Hong Kong

Phone: 852-35052803

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
6 February 2025
Est. completion
13 June 2027

Where this trial is recruiting

Hong Kong

Primary endpoints

Change of quality of life by Uterine Fibroid Symptom health-related Quality of Life questionnaire (UFS-QOL) from baseline to 3 months after HIFU or myomectomy; Change of quality of life by Uterine Fibroid Symptom health-related Quality of Life questionnaire (UFS-QOL) from baseline to 6 months after HIFU or myomectomy

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov